The following guideline can be ordered through the address listed in the "Source/Publisher"-category. In cases in which you can order through the Internet we have established a hyperlink.

ICH M7(R1) Assessment and Control of DNA reactive (mutagenic) Impurities in Pharmaceuticals to limit potential carcinogenic risk

Short Title:

Document Type:
ICH Guideline
This guideline emphasizes considerations of both safety and quality risk management in establishing levels of mutagenic impurities

Go back

GMP Conferences by Topics

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information